SpaceX has filed for an IPO with a target valuation of $1.75 to $2 trillion, potentially making CEO Elon Musk a trillionaire. Congresswoman Lisa McClain owns a stake in SpaceX through a prior investment in xAI, which merged with SpaceX. Depending on the IPO valuation, her stake could yield profits up to $150,000, about 86% of her $174,000 annual salary. McClain has disclosed other private investments and has been a top gainer among Congress members in 2025. Restrictions likely apply on when she can sell the shares, but the IPO could significantly increase her wealth.
Leggett & Platt's Board declared a second quarter dividend of $0.05 per share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. At the company's annual meeting, shareholders elected all eight board nominees, ratified Pricewate...
Zoom Video Communications will report Q1 earnings on May 21, 2026, with analysts expecting $1.41 EPS and $1.22 billion revenue, a 4.2% increase from last year. Growth is driven by AI expansion and strong Zoom Phone service adoption, despite a slight ...
At its May 21, 2026 Annual General Meeting, Nexans shareholders approved all 22 board resolutions, including an 11.5% increase in dividends to €2.90 per share payable on May 27. The meeting also renewed independent board members Laura Bernardelli and...
At its 2026 Annual Shareholders' Meeting, Nexans approved all 22 board resolutions, including an 11.5% increase in dividends to €2.90 per share payable in May. The meeting also renewed two independent directors and appointed two new ones, resulting i...
Over 30 pharmaceutical companies are actively developing more than 30 drugs for cutaneous T-cell lymphoma (CTCL), a rare skin-related non-Hodgkin lymphoma. Key players like Prescient Therapeutics and Innate Pharma are advancing promising therapies th...
